Business Segments · Product revenues, net
Business Segments — Product revenues, net
Vertex Pharmaceuticals Business Segments — Product revenues, net decreased by 6.4% to $2.99B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 7.8%, from $2.77B to $2.99B. Over 3 years (FY 2022 to FY 2025), Business Segments — Product revenues, net shows an upward trend with a 10.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates strong market adoption and successful commercialization of the drug portfolio.
Detailed definition
Represents the total revenue generated from the sale of pharmaceutical products after accounting for returns, rebates, a...
Peer comparison
Standard across all pharmaceutical companies as 'Net Product Sales'.
Metric ID:
vrtx_segment_pharmaceuticals_product_revenues_netHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.23B | $2.23B | $2.23B | $2.23B | $2.47B | $2.47B | $2.47B | $2.47B | $2.69B | $2.65B | $2.77B | $2.91B | $2.77B | $2.96B | $3.08B | $3.19B | $2.99B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +10.5% | +0.0% | +0.0% | +0.0% | +9.1% | -1.7% | +4.8% | +5.1% | -4.9% | +7.0% | +3.8% | +3.7% | -6.4% |
| YoY Change | — | — | — | — | +10.5% | +10.5% | +10.5% | +10.5% | +9.1% | +7.2% | +12.3% | +18.0% | +3.0% | +12.1% | +11.0% | +9.5% | +7.8% |
Range$2.23B – $3.19B
CAGR+7.5%
Avg YoY Growth+10.2%
Median YoY Growth+10.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's business segments — product revenues, net?
- Vertex Pharmaceuticals (VRTX) reported business segments — product revenues, net of $2.99B in Q1 2026.
- How has Vertex Pharmaceuticals's business segments — product revenues, net changed year-over-year?
- Vertex Pharmaceuticals's business segments — product revenues, net increased by 7.8% year-over-year, from $2.77B to $2.99B.
- What is the long-term trend for Vertex Pharmaceuticals's business segments — product revenues, net?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's business segments — product revenues, net has grown at a 10.4% compound annual growth rate (CAGR), from $8.93B to $12B.
- What does business segments — product revenues, net mean?
- The total money earned from selling drugs after subtracting sales-related deductions.